LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Wednesday’s analyst calls: Street reacts to Oracle AI announcements, Goldman downgrades shoe stock

Chaim Potok by Chaim Potok
June 12, 2024
in Investing
Wednesday’s analyst calls: Street reacts to Oracle AI announcements, Goldman downgrades shoe stock
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


(This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) A software giant and a shoe stock were among the stocks being talked about on Wall Street. Analysts reacted to Oracle’s latest quarterly figures as well as some announcements made around artificial intelligence. Meanwhile, Goldman Sachs downgraded Birkenstock to neutral. Check out the latest calls and chatter below. All times ET. 6:01 a.m.: Piper Sandler opens overweight rating on Valvoline Piper Sandler came out of the gate with an optimistic call on Valvoline . Analyst Peter Keith initiated coverage of the automobile lube service provider with an overweight rating and a $49 target. At that level, Keith predicts shares will climb 20.7% over Tuesday’s close. “After divesting its Global Products business in early 2023, VVV is now a pure-play quick lube service provider with an attractive growth outlook,” Keith told clients. “Considering a fragmented industry landscape with share gain potential, a multitude of comp sales drivers, and majority of its 7-10% growth coming from franchisee growth – we are comfortable with VVV’s algo for top-line growth of 14-16% and EPS growth of 20%+.” Keith lauded the company’s five-year growth algorithm, while noting the stock is a risk in the next 25 to 30 years as the prevalence of different types of cars shake up the business model. He also pointed to the fact that lube hasn’t seen the same interest from private equity as other after-market services within the auto industry. His call comes amid a respectively weak year for shares. The stock has added around 8% in 2024, underperforming the S & P 500’s gain of more than 12%. — Alex Harring 5:44 a.m.: Wells Fargo gives Skechers ‘the respect it deserves’ with overweight initiation Wells Fargo began coverage on Skechers , saying the footwear maker has earned admiration. Analyst Will Gaertner initiated the stock with an overweight rating with an $83 price target. Gaertner’s target implies shares can rise 12.4% over the next year from Tuesday’s closing level. “We believe it is time to give SKX the respect it deserves,” he told clients. “SKX is a compelling growth story that is underappreciated w/ go-fwd rev & EPS growth tops among softlines. Despite the stock’s recent run, there is more room for upside.” Gaertner called the company’s growth outlook on both lines both attractive yet underappreciated, while he said its margin drivers are sustainable. Meanwhile, he said Skechers is improving its operational discipline. Shares added about 0.5% before the bell on Tuesday. The stock has jumped 18.5% in 2024, propelled by a second-quarter rally of more than 20%. — Alex Harring 5:40 a.m.: Wall Street reacts to Oracle earnings, AI announcements Despite a tough quarter on the surface, analysts and traders found nuggets to like out of Oracle’s earnings report. The software company posted $1.63 in adjusted earnings per share on $14.29 billion in revenue for the fourth fiscal quarter on Monday. That was below the consensus forecasts from analysts polled by LSEG of $1.65 a share and $14.55 in revenue. However, shares popped more than 8% on the back of cloud deals with Google and Open AI. Firms such as Morgan Stanley and JPMorgan raised their price targets on the stock following the report, citing reasons for excitement like newly announced artificial intelligence deals. Here’s what some on Wall Street had to say: JPMorgan analyst Mark Murphy (neutral rating, price target raise of $5 to $110, 11.2% downside ahead): “Stepping back, while we see this one quarter differently and do not sense investors using the most intellectually-robust framework at the moment, we continue to respect what Oracle has accomplished in terms of margin structure, developing OCI and positioning the business to reaccelerate, and we continue to apply a high growth-adjusted PT multiple to reflect these merits.” Morgan Stanley analyst Keith Weiss (equal-weight rating, price target increase by $10 to $125, 0.9% upside ahead): “The positive of signing 30 OCI customers driving $12.5B in AI bookings outweighed the negatives of revs and EPS missing in Q4, with notable decelerations in SaaS apps. In an environment rewarding hardware vendors participating in the AI build-out, this likely supports positive momentum in ORCL.” Piper Sandler analyst Brent Bracelin (overweight rating, price target hike by $10 to $150, sees upside of 21.1%): “The $12.5B of new AI contract signings reaffirms that ORCL is one of the few software titans (alongside MSFT) that appears to be capitalizing on the generative AI wave now underway”. — Alex Harring 5:40 a.m.: Goldman Sachs downgrades Birkenstock It might be time to cash in on Birkenstock gains, according to Goldman Sachs. Analyst Louise Singlehurst downgraded the German shoe stock to neutral from buy. Singlehurst raised her price target to $58 from $54.20, but the new forecast implies nearly 2% downside from Tuesday’s close. Share have been on fire this year, rising more than 21%. BIRK YTD mountain BIRK year to date “We like the investment thesis at Birkenstock, supported by share gains in a highly fragmented market, new product launches with additional production facilities to ease supply constraints, positive price mix and best in class levels of operating profitability,” the analyst wrote. “However, since listing in October 2023 the shares have outperformed the broader luxury peer group by c.43%; the S & P 500 +24%; and Stoxx 600 +32%, and we now view the shares as fairly valued,” she added. Birkenstock shares were down more than 3% in the premarket following the downgrade. — Fred Imbert



Source link

You might also like

Top Wall Street analysts are bullish on these 3 stocks for the long term

Chinese robots are on a roll. Morgan Stanley shares its favorite plays

Berkshire’s Japanese stock positions top $30 billion

Share30Tweet19
Previous Post

Questions remain seven years on from the Grenfell Tower tragedy | Property Week

Next Post

Zimbabwe consults crypto firms on virtual asset regulation needs

Chaim Potok

Chaim Potok

Recommended For You

Top Wall Street analysts are bullish on these 3 stocks for the long term
Investing

Top Wall Street analysts are bullish on these 3 stocks for the long term

October 12, 2025
Chinese robots are on a roll. Morgan Stanley shares its favorite plays
Investing

Chinese robots are on a roll. Morgan Stanley shares its favorite plays

October 12, 2025
Berkshire’s Japanese stock positions top  billion
Investing

Berkshire’s Japanese stock positions top $30 billion

October 11, 2025
Activist Irenic takes a stake in Atkore, urges company to consider a sale
Investing

Activist Irenic takes a stake in Atkore, urges company to consider a sale

October 11, 2025
Next Post
Zimbabwe consults crypto firms on virtual asset regulation needs

Zimbabwe consults crypto firms on virtual asset regulation needs

Related News

Is it worth upgrading? Why now is the perfect time to sell your iPhone – London Business News | London Wallet

Is it worth upgrading? Why now is the perfect time to sell your iPhone – London Business News | London Wallet

October 16, 2024
Attorney General reviewing whether Nottingham attacker sentence too lenient

Attorney General reviewing whether Nottingham attacker sentence too lenient

January 26, 2024
Aldeyra Therapeutics’ stock jumps 11% premarket after announcing positive trial of treatment for allergic conjunctivitis

Aldeyra Therapeutics’ stock jumps 11% premarket after announcing positive trial of treatment for allergic conjunctivitis

June 15, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?